Neurocrine Biosciences shares owned by J. Goldman & Co
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by J. Goldman & Co
from 13F filings
Historical chart of J. Goldman & Co investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by J. Goldman & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by J. Goldman & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $4.9M | 36k | 137.67 |
| 2024-03-31 | $2.7M | 20k | 137.92 |
| 2023-12-31 | $5.1M | 39k | 131.76 |
| 2023-09-30 | $11M | 97k | 112.50 |
| 2023-06-30 | $12M | 125k | 94.30 |
| 2023-03-31 | $883k | 8.7k | 101.22 |
| 2022-09-30 | $4.8M | 45k | 106.20 |
| 2022-06-30 | $739k | 7.6k | 97.47 |
| 2022-03-31 | $638k | 6.8k | 93.82 |
| 2017-03-31 | $2.0M | 47k | 43.30 |